RB

Rashi Bhaskar

Active Director Director DIN 00684254
DIN 00684254 First appointment Oct 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2004
Shareholding value •••• Premium profile

About Rashi Bhaskar

Data last updated:

Rashi Bhaskar is a Director at Trojan Pharma Limited (since 2004). The company operates in Pharma. Trojan Pharma Limited reported revenue of ₹1.66 Cr (FY 2021).

DIN 00684254
Primary Designation Director
Industry Pharma
First Appointment 25 Oct 2004
Oldest Company Age 22 yrs
Largest company Trojan Pharma Limited · ₹1.66 Cr (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Trojan Pharma Limited U24230PB2004PLC027593
Director25 Oct 20042004₹1.66 Cr (FY 2021)Active

Board colleagues of Rashi Bhaskar

NameDINCompanyDesignation
Anil Kumar Bhaskar00684225Trojan Pharma LimitedManaging Director
Bhuvan Bhaskar02988706Trojan Pharma LimitedDirector

Directorship timeline

Open interactive timeline →
Trojan Pharma Limited
Premium access

Shareholding and investment profile for Rashi Bhaskar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashi Bhaskar

Rashi Bhaskar currently holds 1 directorship: Trojan Pharma Limited (Director, since 25 Oct 2004, revenue ₹1.66 Cr (FY 2021)).

Rashi Bhaskar was first appointed on 25 Oct 2004 as Director at Trojan Pharma Limited.

The current boards of Rashi Bhaskar's companies include Anil Kumar Bhaskar (Trojan Pharma Limited), Bhuvan Bhaskar (Trojan Pharma Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available